ALLMedicine™ Prostatic Hyperplasia Center

Mar 14th, 2023 - Recent studies identified several risk factors of benign prostatic hyperplasia (BPH), including dyslipidemia, type 2 diabetes mellitus, hypertension, and obesity. But they were not so reliable and some studies contradicted with one another. Hence,...

Mar 12th, 2023 - Inflammation plays a critical role during benign prostatic hyperplasia (BPH) development. Danzhi qing'e (DZQE) decoction is a traditional Chinese medicine that has been widely used for estrogen and androgen-related diseases. However, its effect on...

Mar 11th, 2023 - Several surgical treatments are available for managing lower urinary tract symptoms secondary to benign prostatic hyperplasia (LUTS/BPH). Water vapour thermal therapy (WVTT) is a new minimally invasive therapy. This study estimates the budget impa...

Mar 10th, 2023 - The objective of this study is to analyze characteristics of recurrent acute urinary retention (AUR) in patients with benign prostatic hyperplasia (BPH), utilizing a population based data set. Also, we sought to report on how AUR was treated, spec...

Mar 10th, 2023 - Clinicians primarily focus on the presence or absence of anterograde ejaculation following surgery for benign prostatic hyperplasia (BPH). Failing to assess dysfunctional ejaculation and associated bother in a granular fashion can underestimate th...

Aug 14th, 2021 - Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and severity of lower urinary tract symptoms (LUTS) in aging men are p...

Jul 24th, 2020 - The AUA Guideline panel provides evidence-based recommendations for the surgical management of male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The Panel amended the Guideline in 2020 to reflect additional ...

May 7th, 2019 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference for effective evidence-based s...

Mar 12th, 2016 - In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medi...

May 9th, 2022 - NEW YORK (Reuters Health) - Aquablation appears to be a safe and effective for treatment for lower-urinary-tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), regardless of prostate volume, new data show. Aquablation using the AquaBea...

Mar 7th, 2022 - NEW YORK (Reuters Health) - Rezum water vapor thermal therapy was safe and effective in patients with benign prostatic hyperplasia (BPH), in a registry study. "This prospectively collected registry of real-world cases shows Rezum to be a fast, eff...

Feb 24th, 2022 - In the largest study of its kind, a series of 9-second shots with barely boiling water into enlarged prostates appears to be a safe and effective approach to treating benign prostatic hyperplasia (BPH), a Canadian-American team reported in the jou...

Jan 20th, 2022 - This transcript has been edited for clarity. I'm Dr Neil Skolnik. Today, I'm going to talk about the American Urologic Association's new guidelines on the management of lower urinary tract symptoms, also called LUTS, due to benign prostatic hyperp...

Sep 1st, 2021 - The American Urological Association (AUA) has updated its guidelines on managing male lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH). The updates, the first since 2010, were summarized in the Journal of Urolog...